185 related articles for article (PubMed ID: 18034391)
1. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis.
Peterson CG; Sangfelt P; Wagner M; Hansson T; Lettesjö H; Carlson M
Scand J Clin Lab Invest; 2007; 67(8):810-20. PubMed ID: 18034391
[TBL] [Abstract][Full Text] [Related]
2. Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study.
Wagner M; Peterson CG; Stolt I; Sangfelt P; Agnarsdottir M; Lampinen M; Carlson M
Scand J Gastroenterol; 2011 Jul; 46(7-8):849-54. PubMed ID: 21557718
[TBL] [Abstract][Full Text] [Related]
3. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
[TBL] [Abstract][Full Text] [Related]
4. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis.
Lettesjö H; Hansson T; Peterson C; Ung KA; Ringström G; Abrahamsson H; Simrén M
Scand J Gastroenterol; 2006 Jan; 41(1):54-9. PubMed ID: 16373277
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of biomarkers for ulcerative colitis comparing two sampling methods: fecal markers reflect colorectal inflammation both macroscopically and on a cellular level.
Peterson CG; Lampinen M; Hansson T; Lidén M; Hällgren R; Carlson M
Scand J Clin Lab Invest; 2016 Sep; 76(5):393-401. PubMed ID: 27223407
[TBL] [Abstract][Full Text] [Related]
6. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
Sugi K; Saitoh O; Hirata I; Katsu K
Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
8. [Application of IL-1 beta and 8 mRNA and some other indices in monitoring the activity of ulcerative colitis].
Zhu F; Qian J; Pan G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):384-9. PubMed ID: 12567438
[TBL] [Abstract][Full Text] [Related]
9. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
Carlson M; Raab Y; Peterson C; Hällgren R; Venge P
Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252
[TBL] [Abstract][Full Text] [Related]
10. Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease.
Wagner M; Peterson CG; Ridefelt P; Sangfelt P; Carlson M
World J Gastroenterol; 2008 Sep; 14(36):5584-9; discussion 5588. PubMed ID: 18810778
[TBL] [Abstract][Full Text] [Related]
11. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.
Masoodi I; Kochhar R; Dutta U; Vaishnavi C; Prasad KK; Vaiphei K; Kaur S; Singh K
J Gastroenterol Hepatol; 2009 Nov; 24(11):1768-74. PubMed ID: 20136960
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
Siddique I; Hasan F; Khan I
Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
[TBL] [Abstract][Full Text] [Related]
13. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of four fecal assays in the diagnosis of colitis.
Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
[TBL] [Abstract][Full Text] [Related]
15. Elevated fecal levels of eosinophil granule proteins predict collagenous colitis in patients referred to colonoscopy due to chronic non-bloody diarrhea.
Wagner M; Sjöberg K; Vigren L; Olesen M; Benoni C; Toth E; Carlson M
Scand J Gastroenterol; 2016 Jul; 51(7):835-41. PubMed ID: 26854205
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis.
Sangfelt P; Carlson M; Thörn M; Lööf L; Raab Y
Am J Gastroenterol; 2001 Apr; 96(4):1085-90. PubMed ID: 11316151
[TBL] [Abstract][Full Text] [Related]
17. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa.
Zwolinska-Wcislo M; Brzozowski T; Budak A; Kwiecien S; Sliwowski Z; Drozdowicz D; Trojanowska D; Rudnicka-Sosin L; Mach T; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2009 Mar; 60(1):107-18. PubMed ID: 19439813
[TBL] [Abstract][Full Text] [Related]
18. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
Mawdsley JE; Jenkins DG; Macey MG; Langmead L; Rampton DS
Am J Gastroenterol; 2008 Jun; 103(6):1460-9. PubMed ID: 18510607
[TBL] [Abstract][Full Text] [Related]
19. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel.
Reimert CM; Tukahebwa EM; Kabatereine NB; Dunne DW; Vennervald BJ
Acta Trop; 2008 Mar; 105(3):253-9. PubMed ID: 18177822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]